Large-scale testing (Phase 3)Study completedNCT03954743
What this trial is testing
Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks
Who this might be right for
Infections, Rotavirus
GlaxoSmithKline 1,351